MYH14 and hereditary sensory and autonomic neuropathy: Latronico & Bolton (2011) reported that CIP and CIM increase hospital mortality in patients who are critically ill and cause chronic disability in survivors due to structural changes like axonal nerve degeneration, skeletal muscle necrosis, and myosin loss. Hence, these type of patients will not only face the long-term effects of severe COVID-19 (Torres-Castro et al., 2021) but also the symptoms of deconditioning due to CIP and CIM, making the rehabilitation process even more complex (Bagnato et al., 2021).